John Hoffman
Family Medicine · Appomattox, VANPI 1457335689
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 559 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,867 and has fallen 99.5% since, to $14 in 2025. Among family medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 559 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$910
- AbbVie$896
- Johnson & Johnson$866
- Amgen$628
- Pfizer$509
- plus $3K from 24 others
What the payments were for
- Food & beverage$8,111100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $1,251 |
| Novo Nordisk | 65 | $910 |
| AbbVie(2 entities) | 78 | $896 |
| Johnson & Johnson | 71 | $866 |
| Amgen | 37 | $628 |
| Pfizer | 51 | $509 |
| Boehringer Ingelheim | 29 | $501 |
| Lilly USA, LLC | 28 | $451 |
| Biohaven Pharmaceuticals, Inc. | 20 | $332 |
| GSK | 25 | $311 |
| Biohaven Pharmaceutical Holding Company Ltd. | 34 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $163 |
| Abbott | 7 | $157 |
| Esperion Therapeutics, Inc. | 8 | $153 |
| Merck | 9 | $126 |
| Amarin Pharma, Inc. | 7 | $124 |
| Sanofi-aventis U.S. LLC | 6 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $80 |
| E.r. Squibb & Sons, L.L.C. | 5 | $69 |
| Arbor Pharmaceuticals, Inc. | 2 | $50 |
| Novartis | 3 | $44 |
| Genentech USA, Inc. | 2 | $38 |
| Bayer | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,138 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Appomattox
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.